Loading stock data…
NovaBridge Biosciences (NBP)
$1.98+0.34 (+20.73%)
After Hours$1.92-0.06 (-3.03%)· Last close Jun 29
NovaBridge Biosciences, a biotechnology company, focuses on the research and development of immuno-oncology agents for the treatment of cancer in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NovaBridge Biosciences in the Healthcare sector is trading at $1.98 with a market capitalization of $202M. Wall Street consensus targets $8.00 (3 analysts), implying a +304.0% move over the next 12 months. The stock is currently near its 52-week low of $1.46, remaining 40.4% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 74 is overbought against a weak tape. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +304.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Overbought RSI 74 against a weak tape — risk of pullback
Quarterly Financials
| Metric (USD) | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$72.90M↓ | -$8.99M↓ | -$7.11M↓ | -$5.27M↑ | -$13.37M |
| Net Income | -$30.79M↓ | -$6.83M↓ | -$5.50M↓ | -$3.15M↑ | -$9.06M |
Peer Comparison
JNJUNHPFE
Fundamentals
NovaBridge Biosciences, a biotechnology company, focuses on the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. It is developi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$202.38M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.56
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-20.03%
Volume
Today's trading volume
4.26M
Recent News
Companies Like NovaBridge Biosciences (NASDAQ:NBP) Can Afford To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Amazon downgraded, Roblox upgraded: Wall Street's top analyst calls
Amazon downgraded, Roblox upgraded: Wall Street's top analyst calls
Insider Spends US$5.1m Buying More Shares In NovaBridge Biosciences
NovaBridge Biosciences ( NASDAQ:NBP ) shareholders (or potential shareholders) will be happy to see that the Executive...
Is There An Opportunity With NovaBridge Biosciences' (NASDAQ:NBP) 40% Undervaluation?
Key Insights The projected fair value for NovaBridge Biosciences is US$6.70 based on 2 Stage Free Cash Flow to Equity...